Development of emergency prophylaxis and treatment of Ebola fever

被引：0
|
作者：
Markin, VA
Mikhailov, VV
KRasnyansky, VP
Borisevich, IV
Firsova, IV
机构：
来源：
VOPROSY VIRUSOLOGII | 1997年 / 42卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The authors validate the efficiency of pathogenetic approach to the development of urgent measures for the prevention and therapy of Ebola fever. The virus circulating in the body is to be blocked as soon as possible and the impaired functions and systems repaired. Therapy of Ebola fever should be based on the earliest possible and sufficiently prolonged administration of specific immunoglobulins in combination with pathogenetic drugs.
引用
收藏
页码：31 / 34
页数：4
相关论文
共 50 条
  • [21] Ebola fever epidemic 2014: a call for sustainable health and development policies
    Steffen Flessa
    Michael Marx
    The European Journal of Health Economics, 2016, 17 : 1 - 4
  • [22] Ebola fever epidemic 2014: a call for sustainable health and development policies
    Flessa, Steffen
    Marx, Michael
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (01): : 1 - 4
  • [23] Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents
    Kiselev, O. I.
    Vasin, A. V.
    Shevyryova, M. P.
    Deeva, E. G.
    Sivak, K. V.
    Egorov, V. V.
    Tsvetkov, V. B.
    Egorov, A. Yu.
    Romanovskaya-Romanko, E. A.
    Stepanova, L. A.
    Komissarov, A. B.
    Tsybalova, L. M.
    Ignatjev, G. M.
    MOLECULAR BIOLOGY, 2015, 49 (04) : 480 - 493
  • [24] Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents
    O. I. Kiselev
    A. V. Vasin
    M. P. Shevyryova
    E. G. Deeva
    K. V. Sivak
    V. V. Egorov
    V. B. Tsvetkov
    A. Yu. Egorov
    E. A. Romanovskaya-Romanko
    L. A. Stepanova
    A. B. Komissarov
    L. M. Tsybalova
    G. M. Ignatjev
    Molecular Biology, 2015, 49 : 480 - 493
  • [25] RECENT STUDIES ON RHEUMATIC FEVER, ITS TREATMENT AND PROPHYLAXIS
    不详
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1961, 85 (16) : 896 - +
  • [26] Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients
    Mupapa, K
    Massamba, M
    Kibadi, K
    Kuvula, K
    Bwaka, A
    Kipasa, M
    Colebunders, R
    Muyembe-Tamfum, JJ
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 : S18 - S23
  • [27] Ebola haemorrhagic fever - a review
    Colebunders, R
    Borchert, N
    JOURNAL OF INFECTION, 2000, 40 (01) : 16 - 20
  • [28] A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever (vol 178, pg 651, 1998)
    Bray, M
    Davis, K
    Geisbert, T
    Schmaljohn, C
    Huggins, J
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05): : 1553 - 1553
  • [29] Pathophysiology of Ebola haemorrhagic fever
    Clark, IA
    Awburn, MM
    Cowden, WB
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (04) : 469 - 469
  • [30] The pathogenesis of Ebola hemorrhagic fever
    Takada, A
    Kawaoka, Y
    TRENDS IN MICROBIOLOGY, 2001, 9 (10) : 506 - 511
12345